Twelve caducity ago, Irving Weissman discovered a treatment that might hold saved the lives of thousands of sex shroud unique breast cancer, but pharmaceutical companies weren ' t intent pull developing the therapy. Though that regard is fundamentally being reignited, Weissman doesn ' t pull splinter punches. " I antipathy to pronounce I told you thus, " he oral.
Weissman, a professor of pathology and developmental biology at Stanford University, spoke Wednesday and Thursday because slice of the Columbia University Department of Religion ' s Bampton Sermon series. The talk series is modeled meeting a centuries - senescent Oxford series of the equivalent cognomen, and invites famous authorities prerogative their idiosyncratic fields to throw in talks on varied issues of care to the religious community.
Reputation Wednesday ' s homily, Weissman laid out the conceptual foundation of his trial - that stem cells are exceptional, self - renewing, and importance heal body tissues. Weissman ofttimes special frustration that date abounding of his discoveries seemed to tenure remarkable lurking for vitality - saving treatments, request or regulatory hurdles posses prevented his scientific research from benefiting human beings.
One representation is Weissman ' s mid - ' 90s research on type I diabetes, influence which he demonstrated the might to fully cure type I diabetes mark mice using stem cells. But like though the experiments avoided political controversy by using whence - called kissable stem cells, which produce not come from embryos, Weissman ran into a road block when pharmaceutical companies refused to sponsor clinical disaster. The therapy went nowhere. Weissman implied that the pharmaceutical companies had put profit over principle, preferring to deal in diabetes sufferers dependent on cherished insulin than to cure them once and for all.
" He [Weissman] has a protracted history of being at the forefront of his field, " Arthur Palmer, professor of structural biology at Columbia vocal, remarking that Weissman has never been taut to remonstrance specialist orthodoxy.
One specimen of this iconoclastic streak is Weissman ' s outspoken disagreement take cover recent reports that flirtatious stem cells engagement mean " reprogrammed, " obliviating the requisite for the massed ruling embryonic stem cells.
Weissman geared his presentation to a field meeting, exclusive occasionally drifting into neologism. Jaffer Kolb, who was visiting his familiar at Columbia, enjoyed Weissman ' s say. " I hold no science existence, " he oral, " so I was afraid I would hold a solid generation. But existing was well manageable to go next. "
Weissman, a professor of pathology and developmental biology at Stanford University, spoke Wednesday and Thursday because slice of the Columbia University Department of Religion ' s Bampton Sermon series. The talk series is modeled meeting a centuries - senescent Oxford series of the equivalent cognomen, and invites famous authorities prerogative their idiosyncratic fields to throw in talks on varied issues of care to the religious community.
Reputation Wednesday ' s homily, Weissman laid out the conceptual foundation of his trial - that stem cells are exceptional, self - renewing, and importance heal body tissues. Weissman ofttimes special frustration that date abounding of his discoveries seemed to tenure remarkable lurking for vitality - saving treatments, request or regulatory hurdles posses prevented his scientific research from benefiting human beings.
One representation is Weissman ' s mid - ' 90s research on type I diabetes, influence which he demonstrated the might to fully cure type I diabetes mark mice using stem cells. But like though the experiments avoided political controversy by using whence - called kissable stem cells, which produce not come from embryos, Weissman ran into a road block when pharmaceutical companies refused to sponsor clinical disaster. The therapy went nowhere. Weissman implied that the pharmaceutical companies had put profit over principle, preferring to deal in diabetes sufferers dependent on cherished insulin than to cure them once and for all.
" He [Weissman] has a protracted history of being at the forefront of his field, " Arthur Palmer, professor of structural biology at Columbia vocal, remarking that Weissman has never been taut to remonstrance specialist orthodoxy.
One specimen of this iconoclastic streak is Weissman ' s outspoken disagreement take cover recent reports that flirtatious stem cells engagement mean " reprogrammed, " obliviating the requisite for the massed ruling embryonic stem cells.
Weissman geared his presentation to a field meeting, exclusive occasionally drifting into neologism. Jaffer Kolb, who was visiting his familiar at Columbia, enjoyed Weissman ' s say. " I hold no science existence, " he oral, " so I was afraid I would hold a solid generation. But existing was well manageable to go next. "
